For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
The closing price of Ideaya Biosciences Inc (NASDAQ: IDYA) was $26.83 for the day, up 4.44% from the previous closing price of $25.69. In other words, the price has increased by $4.44 from its previous closing price. On the day, 1.85 million shares were traded. IDYA stock price reached its highest trading level at $27.28 during the session, while it also had its lowest trading level at $25.54.
Ratios:
Our analysis of IDYA’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 12.39 and its Current Ratio is at 12.39. In the meantime, Its Debt-to-Equity ratio is 0.03 whereas as Long-Term Debt/Eq ratio is at 0.03.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of . The stock’s future direction. In the most recent recommendation for this company, Guggenheim on September 18, 2025, initiated with a Buy rating and assigned the stock a target price of $50.
On September 04, 2025, Citizens JMP started tracking the stock assigning a Mkt Outperform rating and target price of $41.
On September 04, 2025, Barclays started tracking the stock assigning a Overweight rating and target price of $40.Barclays initiated its Overweight rating on September 04, 2025, with a $40 target price.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, IDYA now has a Market Capitalization of 2351480064 and an Enterprise Value of 1708339072. For the stock, the TTM Price-to-Sale (P/S) ratio is 335.93 while its Price-to-Book (P/B) ratio in mrq is 2.45. Its current Enterprise Value per Revenue stands at 244.048 whereas that against EBITDA is -4.475.
Stock Price History:
The Beta on a monthly basis for IDYA is 0.13, which has changed by -0.15309346 over the last 52 weeks, in comparison to a change of 0.1529237 over the same period for the S&P500. Over the past 52 weeks, IDYA has reached a high of $32.67, while it has fallen to a 52-week low of $13.45. The 50-Day Moving Average of the stock is 9.13%, while the 200-Day Moving Average is calculated to be 22.63%.
Shares Statistics:
IDYA traded an average of 1.13M shares per day over the past three months and 1248420 shares per day over the past ten days. A total of 87.64M shares are outstanding, with a floating share count of 80.64M. Insiders hold about 8.00% of the company’s shares, while institutions hold 104.10% stake in the company. Shares short for IDYA as of 1757894400 were 9459498 with a Short Ratio of 8.38, compared to 1755216000 on 9648848. Therefore, it implies a Short% of Shares Outstanding of 9459498 and a Short% of Float of 12.740000000000002.
Earnings Estimates
. The current assessment of Ideaya Biosciences Inc (IDYA) involves the perspectives of 15.0 analysts closely monitoring its market dynamics.The consensus estimate for the next quarter is -$0.87, with high estimates of -$0.61 and low estimates of -$1.03.
Analysts are recommending an EPS of between -$0.98 and -$3.67 for the fiscal current year, implying an average EPS of -$3.1. EPS for the following year is -$3.33, with 16.0 analysts recommending between -$2.4 and -$4.11.
